Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 Diabetes

clinical trial

Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 Diabetes is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT01615978

P6099clinical trial phasephase I clinical trialQ5452194
P17countryJapanQ17
P582end time2004-03-01
P4135maximum age64
P1050medical conditiondiabetesQ12206
P2899minimum age20
P1132number of participants15
P4844research interventionliraglutideQ2526479
P6153research siteNovo NordiskQ818846
P580start time2003-12-01
P8363study typeinterventional studyQ78089383
P1476titleA Randomised, Double-blind Within Dose Group, Single-centre, Placebo-controlled, Parallel 2-different Dose Group, 14-day Multiple s.c. Doses Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Liraglutide (NNC 90-1170) in Subjects With Type 2 Diabetes

Search more.